Both in Pharmaceuticals
Ultragenyx Pharmaceutical vs Phibro Animal Health
Over the past year RARE returned −53.0% and PAHC returned +0.8%; their daily moves had a correlation of 0.09.
RARE −53.0% PAHC +0.8%Growth of $1, one year, split-adjusted
| Metric | RARE | PAHC |
|---|---|---|
| Price | $14.90 | $37.93 |
| Market cap | $1.47B | $1.54B |
| Today | −0.13% | +3.04% |
| 1 month | +14.0% | +8.3% |
| 6 months | −40.8% | −31.0% |
| Year to date | −35.2% | +1.5% |
| 1 year | −53.5% | +3.7% |
| Revenue growth (YoY) | +28.1% | +4.8% |
| Gross margin | 84.1% | 33.9% |
| Net margin | −43.0% | 5.5% |
| P/E (TTM) | — | 15.4× |
| Price / sales | 2.0× | 1.0× |
| Net cash | $292.0M | -$650.8M |
| Dividend yield | — | 1.27% |
| Volatility (60d) | 127.6% | 31.0% |
| Short % of float | 21.8% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).